NCT00642941 2021-02-03
A Study of R1507 in Participants With Recurrent or Refractory Sarcoma
Hoffmann-La Roche
Phase 2 Terminated
Clinical Trials
8 trialsNCT00760929 2021-01-05
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).
Hoffmann-La Roche
Phase 2 Terminated
NCT00796107 2020-11-13
A Study of R1507 in Combination With Letrozole in Postmenopausal Women With Advanced Breast Cancer
Hoffmann-La Roche
Phase 2 Terminated
NCT00400361 2016-11-02
A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.
Hoffmann-La Roche
Phase 1 Completed
NCT00882674 2016-11-02
A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer
Hoffmann-La Roche
Phase 1 Completed
NCT00985374 2016-11-02
A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors
Hoffmann-La Roche
Phase 1 Terminated
NCT00560144 2016-11-01
A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.
Hoffmann-La Roche
Phase 1 Completed
NCT00773383 2013-06-24
A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC) Having Received Tarceva Monotherapy.
Hoffmann-La Roche
Phase 2 Terminated